Prevalence and impact of depression on COPD

J. Rigual Bobillo (VALLADOLID, Spain)

Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Session: Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Session type: Thematic Poster
Number: 945
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Rigual Bobillo (VALLADOLID, Spain). Prevalence and impact of depression on COPD. 945

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and risk factors of depression in patients with COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


Effect of depression and anxiety on the risk of exacerbation and hospitalization in COPD
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008

Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003


Prevalence and characteristics of anxiety and depression in patients with advanced COPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015

COPD and depression
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

High prevalence of current smokers among COPD patients with anxiety and depression symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001

Prevalence of anxiety and depression in COPD: are females at higher risk?
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005

Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011


The prevalence of anxiety and depression in a COPD outreach population
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

The impact of anxiety and depression on outcomes of pulmonary rehabilitation in COPD
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011

The impact of depression and anxiety on never-smokers COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


The effect of different tools in assessing the prevalence of depression in COPD patients
Source: Annual Congress 2008 - Quality of life and mood disturbances in rehabilitation
Year: 2008

Impact of pulmonary rehabilitation on anxiety and depression in patients with COPD
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008

Obesity in pediatric asthma: prevalence and impact on severity
Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology
Year: 2017

The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011

Prevalence and underdiagnosis of COPD by disease severity in middle-aged and elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 470s
Year: 2005

The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
Source: Eur Respir J 2013; 41: 815-823
Year: 2013



Prevalence of COPD and comorbidity
Source: Eur Respir Mon 2013; 59: 1-12
Year: 2013


Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021


Impact of stable state symptoms on the future burden of COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018